Neuronetics stock tumbles 10% on stock offering launch
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Neuronetics Inc (NASDAQ:STIM) shares dropped 10% in after-hours trading after the company announced a public offering of common stock and an amendment to its credit agreement. The mental health technology company plans to sell all shares in the offering and has granted underwriters a 30-day option for an additional 15%.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.